S1PR1 and ventilator-associated pneumonia: Although inhibiting S1PR1 slows egress of lymphocytes from lymph nodes and reduces the number of circulating lymphocytes, no obvious increase of Th2 cells was observed at 8 h vs. baseline in VAP (Fig. 3a).